毛绩伟,王喆,王漂,等.VEGFR2/STAT3/MMP-9介导阿帕替尼抑制辐射后鼻咽癌细胞迁移[J].中华放射医学与防护杂志,2019,39(7):481-486.Mao Jiwei,Wang Zhe,Wang Piao,et al.VEGFR2/STAT3/MMP-9 mediates apatinib-inhibited migration of nasopharyngeal carcinoma cells after radiation[J].Chin J Radiol Med Prot,2019,39(7):481-486
VEGFR2/STAT3/MMP-9介导阿帕替尼抑制辐射后鼻咽癌细胞迁移
VEGFR2/STAT3/MMP-9 mediates apatinib-inhibited migration of nasopharyngeal carcinoma cells after radiation
投稿时间:2019-02-20  
DOI:10.3760/cma.j.issn.0254-5098.2019.07.001
中文关键词:  鼻咽癌  阿帕替尼  迁移  基质金属蛋白酶  上皮间质转化
英文关键词:Nasopharyngeal carcinoma  Apatinib  Migration  MMP-9  EMT
基金项目:国家自然科学基金(81501753)
作者单位E-mail
毛绩伟 大连大学附属中山医院肿瘤科 116001  
王喆 大连大学附属中山医院肿瘤科 116001  
王漂 大连大学附属中山医院肿瘤科 116001  
梁珊珊 辽宁省乳腺及消化肿瘤分子标志物高通量筛选及靶向药物转化重点实验室, 大连 116001  
鞠再双 大连大学附属中山医院肿瘤科 116001  
杨亮 大连大学附属中山医院肿瘤科 116001  
蔡龙玉 大连大学附属中山医院肿瘤科 116001  
王若雨 大连大学附属中山医院肿瘤科 116001 wangruoyu1963@163.com 
摘要点击次数: 3459
全文下载次数: 1664
中文摘要:
      目的 探讨阿帕替尼对X射线照射后鼻咽癌细胞迁移能力的影响及机制。方法 通过划痕实验比较人永生化鼻咽上皮细胞(NP69)和鼻咽癌细胞(CNE-1、CNE-2)的迁移能力,以及不同浓度阿帕替尼(0、5、10和15 μmol/L)对其的影响;通过CCK-8检测阿帕替尼对鼻咽癌细胞活性的影响,确定药物干预浓度;将鼻咽癌细胞分为对照组、阿帕替尼组(15 μmol/L)、照射组和阿帕替尼联合照射组,检测各组迁移能力;通过Western blot检测各实验组磷酸化血管内皮细胞生长因子受体2(pVEGFR2)、磷酸化信号传导及转录激活因子(pSTAT3)、STAT3、基质金属蛋白酶(MMP-9)和上皮间质转化(EMT)相关信号通路激活与蛋白表达的变化。结果 与人永生化鼻咽上皮细胞(NP69)相比,鼻咽癌细胞CNE-1和CNE-2迁移能力明显更强(t=-5.759、-16.578,P<0.05);与对照组相比,鼻咽癌细胞在阿帕替尼(5、10和15 μmol/L)干预后迁移能力明显降低,并具有剂量依赖性(t=2.804~13.362,P<0.05);与照射组相比,阿帕替尼联合照射组的鼻咽癌细胞划痕愈合速率降低(t=5.932、2.791,P<0.05),说明阿帕替尼可以明显抑制X射线照射后鼻咽癌细胞的迁移;Western blot结果显示,鼻咽癌细胞经过阿帕替尼处理后,磷酸化的VEGFR2和STAT3表达显著下降,同时,MMP-9蛋白表达明显下降,EMT相关蛋白发生变化。结论 阿帕替尼可能通过下调VEGFR2/STAT3/MMP-9信号通路抑制鼻咽癌细胞EMT化,从而抑制X射线照射后鼻咽癌细胞的迁移。
英文摘要:
      Objective To investigate the effect of apatinib on the migration ability of nasopharyngeal carcinoma NPC cells after X-ray irradiation and involved protein expressions. Methods The migration abilities of human immortalized nasopharyngeal epithelial cells (NP69) and nasopharyngeal carcinoma cells (CNE-1, CNE-2) treated with different concentrations of apatinib (0, 5, 10 and 15 μmol/L) were compared by wound healing assay. The effect of apatinib on the activity of NPC cells was detected by CCK-8 for determining the suitable intervention concentration of apatinib. Then NPC cells were divided into control group, apatinib group (15 μmol/L), X-ray irradiation group and apatinib combined with X-ray irradiation group, and the migration ability of each group was compared by wound healing assay. The expressions of pVEGFR2, pSTAT3, STAT3, MMP-9 and EMT related proteins were detected by western blot. Results Compared with the NP69, the migration abilities of CNE-1 and CNE-2 were significantly enhanced (t=-5.759, -16.578, P<0.05). Compared with the control group (0 μmol/L), the migration ability of NPC cells after treatment with apatinib(5, 10 and 15 μmol/L)was significantly decreased in a concentration dependent manner (t=2.804-13.362, P<0.05). Compared with the X-ray irradiation group, the wound healing rate of NPC cells in the apatinib combined with X-ray irradiation group was decreased (t=5.932, 2.791, P<0.05), indicating that apatinib can significantly inhibit the migration of NPC cells after X-ray irradiation. Western blot assay showed that the expressions of pVEGFR2 and pSTAT3 were significantly decreased in NPC cells treated with apatinib, meanwhile, the expression of MMP-9 protein was significantly decreased, and the EMT-related protein was changed. Conclusions Apatinib inhibits migration of X-ray irradiated NPC cells by inhibiting EMT through down-regulating VEGFR2/STAT3/MMP-9 signaling pathway.
HTML  查看全文  查看/发表评论  下载PDF阅读器
关闭